Search research articles
Contact Us
Filters
Showing results (201-210 of 218) with videos related to
Page
of 22
Sort By:
The British Journal of Dermatology
|
February 26, 2016
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
K A Papp, K Reich, C Paul, et al.
Contact Dermatitis
|
June 20, 1998
Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy
A Schnuch, G A Westphal, M M Müller, et al.
Archives of Dermatological Research
|
February 22, 2012
German S3-guidelines on the treatment of psoriasis vulgaris (short version)
A Nast, W H Boehncke, U Mrowietz, et al.
Archives of Dermatological Research
|
September 22, 2010
Definition of treatment goals for moderate to severe psoriasis: a European consensus
U Mrowietz, K Kragballe, K Reich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 9, 2011
[New information about fumaric acid esters (Fumaderm): results of a workshop of experts]
Ulrich Mrowietz, A Adamczyk, M Augustin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 13, 2017
European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC
A Nast, P I Spuls, G van der Kraaij, et al.
Archives of Dermatological Research
|
May 15, 2007
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
A Nast, I Kopp, M Augustin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 21, 2015
European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC
A Nast, P Gisondi, A D Ormerod, et al.
The British Journal of Dermatology
|
January 30, 2020
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials
E L Simpson, J-P Lacour, L Spelman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 3, 2018
Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice
J-T Maul, A A Navarini, R Sommer, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 218) with videos related to
Sort By:
Page
of 22
The British Journal of Dermatology
|
February 26, 2016
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
K A Papp, K Reich, C Paul, et al.
Contact Dermatitis
|
June 20, 1998
Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy
A Schnuch, G A Westphal, M M Müller, et al.
Archives of Dermatological Research
|
February 22, 2012
German S3-guidelines on the treatment of psoriasis vulgaris (short version)
A Nast, W H Boehncke, U Mrowietz, et al.
Archives of Dermatological Research
|
September 22, 2010
Definition of treatment goals for moderate to severe psoriasis: a European consensus
U Mrowietz, K Kragballe, K Reich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 9, 2011
[New information about fumaric acid esters (Fumaderm): results of a workshop of experts]
Ulrich Mrowietz, A Adamczyk, M Augustin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 13, 2017
European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC
A Nast, P I Spuls, G van der Kraaij, et al.
Archives of Dermatological Research
|
May 15, 2007
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
A Nast, I Kopp, M Augustin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 21, 2015
European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC
A Nast, P Gisondi, A D Ormerod, et al.
The British Journal of Dermatology
|
January 30, 2020
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials
E L Simpson, J-P Lacour, L Spelman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 3, 2018
Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice
J-T Maul, A A Navarini, R Sommer, et al.
Page
of 22